Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vomeronasal 1 receptor 31 pseudogene (VN1R31P) is classified as a pseudogene in the human genome[3][5][7]. It is related by sequence to the vomeronasal 1 receptor family, which are class A (rhodopsin-like) G protein-coupled receptors involved in pheromone detection in many species. However, as VN1R31P is a pseudogene, it contains sequence features that render it nonfunctional and it is not believed to encode an active or functional receptor protein in humans[3][7]. Pseudogenes such as VN1R31P are generally not involved in therapeutic targeting, biological functions, drug interactions, biomarker roles, or disease associations, but may be of interest for comparative genomics and evolutionary studies[3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vomeronasal 1 receptor 31 pseudogene (VN1R31P).